← Leaderboards
Melvin E Klegerman
University Of Texas Hlth Ctr At Tyler
$1,249,831
Attributed
$2,499,662
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $645.7K · FY2021–24$1M$750K$500K$250K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,499,662 · 1
By mechanism
R01$2,499,662 · 1
Top collaborators
- Andrey Komissarov4 shared
Most similar at University Of Texas Hlth Ctr At Tyler
Same institution · by research overlap
- Steven Idell$6,820,677
- Andrey Komissarov$3,479,251
- Torry Alle Tucker$3,028,800
- Galina Florova$1,545,576
- Guoqing Qian$1,204,269
Others in their field
Other Emerging Leaders on “Fibrinolysis”
- James Craig Hartman · Mdi Therapeutics, Inc.$3,645,392
- Eva Mistry · Vanderbilt University Medical Center$3,345,493
- Prashant Kishore Purohit · University Of Pennsylvania$2,506,876
- Angelo D'alessandro · University Of Colorado Denver$2,200,921
- Sun Yong Jeong · Translational Sciences, Inc.$2,133,619
- Laibaik Park · Weill Medical Coll Of Cornell Univ$2,118,750
Research focus
FibrinolysisAffinityFibrinAcuteBench To BedsideBiochemical3-DimensionalAnimalsChronicCoagulation ProcessCommercializationComorbidityComplexComplicationBiophysicsDesignDoseDrug KineticsEarly Phase Clinical TrialEffusionElderlyEmpyemaEncapsulatedFormulation
Grant awards (4)
Enhanced Delivery of Thrombolytic Carriers for Empyema$609,709
R01 · FY2024 · HL
Enhanced Delivery of Thrombolytic Carriers for Empyema$622,151
R01 · FY2023 · HL
Enhanced Delivery of Thrombolytic Carriers for Empyema$622,151
R01 · FY2022 · HL
Enhanced Delivery of Thrombolytic Carriers for Empyema$645,651
R01 · FY2021 · HL